Patients undergoing surgery receive state-of-the-art care from a multidisciplinary team of physicians and nurses dedicated to treating lung cancer, mesothelioma, esophageal cancer, and disease that has metastasized to the lungs. The program also treats less common malignancies including sarcomas and tumors of the thymus, mediastinum, bronchus and chest wall. Because physicians in the program are also leading clinical investigators, patients can also enroll in clinical trials testing the most promising new treatments.